Close

Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
(NASDAQ: VRCA) Delayed: 6.65 -0.14 (2.06%)
Previous Close $6.79    52 Week High $ 
Open $6.79    52 Week Low $ 
Day High $6.95    P/E N/A 
Day Low $6.60    EPS $ 
Volume 297,436